(Press-News.org) INDIANAPOLIS – A significant obstacle to improving care and outcomes for intensive care unit (ICU) patients is the unexpected nature of becoming seriously ill. Which groups of patients are likely to become severely ill and will they survive their ICU stay?
In a first step in creating infrastructure for further studies to identify and follow cohorts of patients who may become critically ill, researchers including Sikandar Khan, D.O, M.S., of Regenstrief Institute and Indiana University School of Medicine, have developed and conducted initial testing of the Prediction Risk Score. Harnessing information available in a health system’s electronic health records, this novel population health tool enables health systems and researchers to better identify groups of patients at risk of being admitted to an ICU in the future and their potential outcomes. ICU survivors are at risk for ICU-acquired cognitive and physical function impairments and may require extensive post-ICU care.
Because the growing population of middle-age individuals is equally at risk for poor health outcomes as older patients, the researchers developed the scoring system to identify at-risk patients as young as age 50.
“Our Risk Prediction Score tool is designed to be used by health systems and researchers so they can engage with adults in a certain population -- perhaps those with certain specific health issues or those living in a specific geographic area -- who may be at higher risk of ICU admission and higher or lower risk of ICU survival,” said Dr. Khan. “The good news is that if researchers are able to identify populations likely to become future ICU patients using the Prediction Risk Score, they may be able to enroll patients in these populations in studies earlier, and health systems may be able to develop new programs and new models of care for at-risk populations to improve the outcomes of individual patients in and after the ICU.
“Currently we have imprecise tools to identify which groups of patients will become severely ill. This study presents the first step in creating infrastructure for further research by us and others to identify and follow cohorts of patients who may become critically ill and ultimately to improve their outcomes.”
“Development of a population-level prediction model for intensive care unit (ICU) survivorship and mortality in older adults: A population-based cohort study” is published in the peer-reviewed journal Health Science Reports. The study was supported by the National Institutes of Health’s National Institute on Aging.
Regenstrief Institute authors, in addition to Dr. Sikandar Khan are Malaz Boustani, M.D., MPH, and co-senior author Babar Khan, M.D., M.S.
All authors and affiliations
Sikandar H. Khan1,2,3, Anthony J. Perkins4, Mikita Fuchita5, Emma Holler6, Damaris Ortiz7, Malaz Boustani8, Babar A Khan1,2,3, Sujuan Gao4.
1Division of Pulmonary, Critical Care Sleep and Occupational Medicine Indianapolis Indiana USA.
2Regenstrief Institute Indiana University Center for Aging Research Indianapolis Indiana USA.
3Department of Medicine Indiana University School of Medicine Indianapolis Indiana USA.
4Department of Biostatistics and Health Data Science Indiana University School of Medicine Indianapolis Indiana USA.
5Department of Anesthesiology University of Colorado Anschutz Medical Campus Aurora Colorado USA.
6Department of Epidemiology and Biostatistics Indiana University School of Public Health Bloomington Indiana USA.
7Department of Surgery Indiana University School of Medicine Indianapolis Indiana USA.
8Center for Health Innovation and Implementation Science Indiana University School of Medicine Indianapolis Indiana USA.
Sikandar Khan, D.O., M.S.
In addition to his role as a research scientist and co-program director of the COVID-19 recovery program for older adults with the Indiana University Center for Aging Research at Regenstrief Institute, Dr. Khan is an assistant professor of medicine and director of the Indiana University Health Intensive Care Unit (ICU) Survivor Center.
About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform clinical practice and improve the lives of patients around the globe.
Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.
About IU School of Medicine
IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.
END
New population risk prediction model for likelihood of ICU admission and survival
2024-01-04
ELSE PRESS RELEASES FROM THIS DATE:
Chung-Ang University study reveals a higher market valuation of cash holdings of firms adopting electronic voting
2024-01-04
Firms worldwide are increasingly adopting electronic voting, enabling shareholders to cast their votes online, instead of attending shareholder meetings in-person. Shareholders can enjoy superior accessibility to the meetings with electronic voting, compared to those with traditional and in-person setups. Despite the emerging popularity of electronic voting in recent years, however, there is limited evidence of its impact on governance.
To address this gap in research, Associate Professor Wonsuk Ha from the School of Business Administration, Chung-Ang University, along ...
Women undergoing fertility treatment who are stressed may have heart health issues during pregnancy
2024-01-04
WASHINGTON—A new Journal of the Endocrine Society study among women attending a fertility center found that those with more stress before pregnancy had higher blood sugar levels during pregnancy, which is a sign of weaker cardiovascular health.
People’s stress levels have continued to rise over the years, particularly in the last few years due to the COVID-19 pandemic, putting them at risk for serious health issues such as heart disease. Research shows women may experience more stress than men, especially those going through infertility. Maintaining a healthy pregnancy ...
Study finds preconception stress may affect health of women undergoing fertility treatment
2024-01-04
Stress during pregnancy is known to influence health outcomes, but a new study from Mass General Brigham researchers suggests that stress levels before pregnancy are also important to evaluate. Investigators at Massachusetts General Hospital and Brigham and Women’s Hospital analyzed the link between self-reported stress immediately before conception among women seeking fertility care and blood glucose levels, a marker of heart health. The team found that maternal stress during preconception ...
AI-driven study redefines right heart health assessment with novel predictive model
2024-01-04
New York, NY [January 4, 2023]—In a milestone study, researchers from the Icahn School of Medicine at Mount Sinai have harnessed the power of artificial intelligence (AI) to enhance the assessment of the heart’s right ventricle, which sends blood to the lungs.
Conducted by a team using AI-enabled electrocardiogram (AI-ECG) analysis, the research demonstrates that electrocardiograms can effectively predict right-side heart issues, offering a simpler alternative to complex imaging technologies and potentially enhancing patient outcomes.
The findings were described in the December 29 online ...
Better mental, physical health in older people tied to living near nature
2024-01-04
SPOKANE, Wash. – Even small differences in the availability of urban green and blue spaces may be associated with better mental and physical health in older adults, according to a Washington State University study.
The study’s findings showed that having just 10% more forest space in a person’s residential ZIP code was associated with reduced serious psychological distress, which covers mental health problems that require treatment and interfere with people’s social lives, work or school. Similarly, a 10% increase in green space, tree cover, water bodies ...
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health
2024-01-04
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health
LA JOLLA, CA—Scripps Research, a nonprofit biomedical institute ranked one of the most influential in the world for its impact on innovation, will celebrate its 100-year history throughout 2024. This significant milestone marks a century of seminal discoveries in immunology, infectious diseases (such as COVID-19, flu, HIV), neuroscience, heart disease, cancer, and more. The institute has also made strides in groundbreaking chemistry advances, drug development and educational ...
JAMA names seven academic physicians and nurses to new Editorial Fellowship Program
2024-01-04
Chicago, January 4, 2024 — The JAMA Network today announces a new class of seven academic physicians and nurses selected for a new program to provide junior faculty and current research fellows opportunities to learn about biomedical journals and scientific publication. This inaugural group of fellows will spend six months immersed as part of the JAMA editorial team to obtain direct exposure to the editorial review process and enhance their skills in scientific communication.
Fellows will be assigned to a current JAMA editor for mentorship, attend manuscript meetings, participate in discussions about research design, data validity, potential clinical importance, and conduct ...
New technique could improve liver fibrosis treatment
2024-01-04
Chronic liver disease, a growing threat to global health, often progresses silently in its early stages. Detecting its precursor, steatotic liver disease (SLD), and advanced liver fibrosis before complications arise is crucial to prevent devastating outcomes. The newly developed Chronic Liver Disease (CLivD) score offers a promising non-invasive approach to this challenge.
In a recent study involving a US general population sample, researchers explored the CLivD score’s ability to identify SLD and advanced fibrosis, assessed using liver stiffness measurement (LSM). The study also evaluated the potential ...
Hunting for the elusive tetraneutrons with thermal fission
2024-01-04
Tetraneutron is an elusive atomic nucleus consisting of four neutrons, whose existence has been highly debated by scientists. This stems primarily from our lack of knowledge about systems consisting of only neutrons, since most atomic nuclei are usually made of a combination of protons and neutrons. Scientists believe that the experimental observation of a tetraneutron could be the key to exploring new properties of atomic nuclei and answering the age-old question: Can a charge-neutral multineutron system ever exist?
Two recent experimental studies reported the presence of tetraneutrons in bound state and resonant state (a state that decays ...
Understanding the role of a new enzyme in the development of autism spectrum disorder
2024-01-04
Over the past decades, scientists have made substantial progress unveiling the underlying mechanisms behind many psychiatric disorders. Every year, new genetic mutations or protein dysregulations are identified as potential culprits for the symptoms, and sometimes even the root causes of complex neurological diseases, including autism spectrum disorder (ASD), schizophrenia, and Alzheimer’s.
Despite these efforts, the precise roles of several proteins involved in brain function remain obscure. Such is the case for indoleamine 2,3-dioxygenase 2 (IDO2), an enzyme expressed in the brain and metabolized by the ...